| Company type | Public |
|---|---|
|
TSE:
DARO1 ISIN: IRO1DARO0008 | |
| Industry | Pharmaceuticals, chemicals |
| Founded | 1956 (as Darou Pakhsh) 1997 (as Darou Pakhsh Holding) |
| Headquarters | Tehran , Iran |
Area served | Worldwide |
| Products | Veterinary drugs, diagnostic imaging, general and specialty medicines, women's health products, over-the-counter drugs, diabetes care, pesticides, plant biotechnology |
| Owner | TPICO (74.5%) [1] |
| Website | www.dpholding.com |
Darou Pakhsh Holding Company ( Persian: شرکت کارخانجات داروپخش, Shirkæt-e Karxanujat-e Darvipaxesh, lit. drug distribution company) is a major pharmaceutical company in Iran. The company is majority-owned by the Social Security Organization of Iran. The company manufactures, distributes, imports and exports finished products and pharmaceutical raw materials. Darou Pakhsh has an annual turnover of US$400m and claims to have the largest research and development operation of any Iranian drug firm. [2] The company formed a plasmapheresis joint venture with a German medical firm, Biotest AG, in early 2004. [2] Darou Pakhsh is listed on the Tehran Stock Exchange.
History
Initially, the plant had been designed to produce 20 dosage forms.
See also
References
- ^ "Daroupakhsh ( DARO1 ) info". tsetmc.com. Retrieved 2012-05-26.
- ^ a b IRAN: Healthcare and Pharmaceuticals Forecast, Economist Intelligence Unit, August 18, 2008
External links
- Darou Pakhsh Holding Company official website
- Darou Pakhsh Pharmaceutical Manufacturing Company official website
